In vitro affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states in vivo
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in mAbs
- Vol. 12 (1), 1755000
- https://doi.org/10.1080/19420862.2020.1755000
Abstract
The role of brain-derived neurotrophic factor (BDNF) signaling in chronic pain has been well documented. Given the important central role of BDNF in long term plasticity and memory, we sought to engineer a high affinity, peripherally-restricted monoclonal antibody against BDNF to modulate pain. BDNF shares 100% sequence homology across human and rodents; thus, we selected chickens as an alternative immune host for initial antibody generation. Here, we describe the affinity optimization of complementarity-determining region-grafted, chicken-derived R3bH01, an anti-BDNF antibody specifically blocking the TrkB receptor interaction. Antibody optimization led to the identification of B30, which has a > 300-fold improvement in affinity based on BIAcore, an 800-fold improvement in potency in a cell-based pERK assay and demonstrates exquisite selectivity over related neurotrophins. Affinity improvements measured in vitro translated to in vivo pharmacological activity, with B30 demonstrating a 30-fold improvement in potency over parental R3bH01 in a peripheral nerve injury model. We further demonstrate that peripheral BDNF plays a role in maintaining the plasticity of sensory neurons following nerve damage, with B30 reversing neuron hyperexcitability associated with heat and mechanical stimuli in a dose-dependent fashion. In summary, our data demonstrate that effective sequestration of BDNF via a high affinity neutralizing antibody has potential utility in modulating the pathophysiological mechanisms that drive chronic pain states.Keywords
This publication has 66 references indexed in Scilit:
- Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back painPain, 2013
- Microglia Control Neuronal Network Excitability via BDNF SignallingNeural Plasticity, 2013
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural MechanismsNeuron, 2012
- Potassium Channels as a Potential Therapeutic Target for Trigeminal Neuropathic and Inflammatory PainMolecular Pain, 2011
- Reduction in voltage‐gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain‐derived neurotrophic factorJournal of Neurochemistry, 2010
- Expression Patterns of Neurotrophins and Neurotrophin Receptors in Articular Chondrocytes and Inflammatory Infiltrates in Knee Joint ArthritisCells Tissues Organs, 2008
- Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral discArthritis Research & Therapy, 2008
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions B, 2006
- Kinetic Exclusion Assay Technology: Characterization of Molecular InteractionsASSAY and Drug Development Technologies, 2004
- Neurotrophins and nerve injury in the adultPhilosophical Transactions B, 1996